CONTRAFECT CORPORATION
28 WELLS AVENUE, THIRD FLOOR
YONKERS, NY 10701
August 27, 2020
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4720
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Deanna Virginio
Re: CONTRAFECT CORPORATION
Registration Statement on Form S-3 (Registration No. 333-246359)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (Registration No. 333- 246359) (the “Registration Statement”) of ContraFect Corporation (the “Company”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on August 31, 2020, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Please contact Wesley C. Holmes of Latham & Watkins LLP, counsel to the Company, at (617) 948-6027, or in his absence, Peter Handrinos at (617) 948-6060, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
| Very truly yours, | ||
| CONTRAFECT CORPORATION | ||
| By: | /s/ Roger J. Pomerantz, M.D., F.A.C.P. | |
| Name: Roger J. Pomerantz, M.D., F.A.C.P. | ||
| Title: President and Chief Executive Officer | ||
| cc: | Michael Messinger, ContraFect Corporation |
Natalie Bogdanos, Esq., ContraFect Corporation |
Peter N. Handrinos, Latham & Watkins LLP |
Wesley C. Holmes, Latham & Watkins LLP |
